G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $595,898 | +2028.2% | 109,339 | +9777.1% | 0.00% | – |
| Q1 2021 | $28,000 | -71.7% | 1,107 | -79.1% | 0.00% | – |
| Q4 2020 | $99,000 | +421.1% | 5,285 | +235.8% | 0.00% | – |
| Q3 2020 | $19,000 | -67.2% | 1,574 | -42.2% | 0.00% | – |
| Q2 2020 | $58,000 | -48.7% | 2,722 | -36.2% | 0.00% | – |
| Q4 2019 | $113,000 | +66.2% | 4,264 | +43.7% | 0.00% | – |
| Q3 2019 | $68,000 | -20.9% | 2,968 | +5.6% | 0.00% | – |
| Q2 2019 | $86,000 | – | 2,811 | +93600.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 3 | -99.1% | 0.00% | – |
| Q4 2018 | $6,000 | -25.0% | 321 | +122.9% | 0.00% | – |
| Q3 2018 | $8,000 | +33.3% | 144 | -0.7% | 0.00% | – |
| Q2 2018 | $6,000 | – | 145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |